Citrullinated fibronectin inhibits apoptosis and promotes the secretion of pro-inflammatory cytokines in fibroblast-like synoviocytes in rheumatoid arthritis

Arthritis Research and Therapy

Volumn 14, Issue 6, 2012, Pages

  Fan, Lieying ^a   Wang, Qiang ^b   Liu, Rongqing ^c   Zong, Ming ^a   He, Dongyi ^d   Zhang, Hui ^a   Ding, Yuanyuan ^a   Ma, Jianwei ^a  

^a TONGJI UNIVERSITY   (China)

^b Shanghai Zhabei District Central Hospital   (China)

^c NINGXIA MEDICAL UNIVERSITY   (China)

^d Guanghua Hospital of Integrative Medicine   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CITRULLINATED FIBRONECTIN; CYCLIN B1; CYTOKINE; FIBRONECTIN; INTERLEUKIN 1; PROTEIN BAX; PROTEIN BCL 2; SURVIVIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUTACOID; BIRC5 PROTEIN, HUMAN; CITRULLINE; HYDROLASE; INHIBITOR OF APOPTOSIS PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; PEPTIDYLARGININE DEIMINASE TYPE IV;

ADULT; AGED; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; FIBROBLAST LIKE SYNOVIOCYTE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MALE; NICK END LABELING; OSTEOARTHRITIS; PROTEIN AGGREGATION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; SYNOVIUM; CELL CULTURE; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

AGED; APOPTOSIS; ARTHRITIS, RHEUMATOID; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CELLS, CULTURED; CITRULLINE; CYCLIN B1; CYTOKINES; FEMALE; FIBROBLASTS; FIBRONECTINS; GENE EXPRESSION; HUMANS; HYDROLASES; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; INHIBITOR OF APOPTOSIS PROTEINS; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; RANK LIGAND; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SYNOVIAL MEMBRANE;

EID: 84872799570     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4112     Document Type: Article

References (32)

1. Huber LC, Distler O, Tarner I, Gay RE, Gay S, Pap T. Synovial fibroblasts: key players in rheumatoid arthritis. Rheumatology (Oxford) 2006, 45:669-675.
2. Sebbag M, Simon M, Vincent C, Masson-Bessière C, Girbal E, Durieux JJ, Serre G. The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies. J Clin Invest 1995, 95:2672-2679. 10.1172/JCI117969, 295950, 7539459.
3. Baeten D, Peene I, Union A, Meheus L, Sebbag M, Serre G, Veys EM, De Keyser F. Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: relevance to antifilaggrin autoantibodies. Arthritis Rheum 2001, 44:2255-2262. 10.1002/1529-0131(200110)44:10<2255::AID-ART388>3.0.CO;2-#, 11665966.
4. Vossenaar ER, Zendman AJ, van Venrooij WJ, Pruijn GJ. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays 2003, 25:1106-1118. 10.1002/bies.10357, 14579251.
5. Suzuki A, Yamada R, Chang X, Tokuhiro S, Sawada T, Suzuki M, Nagasaki M, Nakayama-Hamada M, Kawaida R, Ono M, Ohtsuki M, Furukawa H, Yoshino S, Yukioka M, Tohma S, Matsubara T, Wakitani S, Teshima R, Nishioka Y, Sekine A, Iida A, Takahashi A, Tsunoda T, Nakamura Y, Yamamoto K. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 2003, 34:395-402. 10.1038/ng1206, 12833157.
6. Borders CL, Broadwater JA, Bekeny PA, Salmon JE, Lee AS, Eldridge AM, Pett VB. A structural role for arginine in proteins: multiple hydrogen bonds to backbone carbonyl oxygens. Protein Sci 1994, 3:541-548. 2142871, 8003972.
7. Masson-Bessière C, Sebbag M, Girbal-Neuhauser E, Nogueira L, Vincent C, Senshu T, Serre G. The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J Immunol 2001, 166:4177-4184.
8. Vossenaar ER, Després N, Lapointe E, van der Heijden A, Lora M, Senshu T, van Venrooij WJ, Ménard HA. Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin. Arthritis Res Ther 2004, 6:R142-R150. 10.1186/ar1149, 400433, 15059278.
9. Burkhardt H, Sehnert B, Bockermann R, Engstrom A, Kalden JR, Holmdahl R. Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis. Eur J Immunol 2005, 35:1643-1652. 10.1002/eji.200526000, 15832289.
10. Kinloch A, Tatzer V, Wait R, Peston D, Lundberg K, Donatien P, Moyes D, Taylor PC, Venables PJ. Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis. Arthritis Res Ther 2005, 7:R1421-R1429. 10.1186/ar1845, 1297593, 16277695.
11. Chang X, Yamada R, Suzuki A, Kochi Y, Sawada T, Yamamoto K. Citrullination of fibronectin in rheumatoid arthritis synovial tissue. Rheumatology 2005, 44:1374-1382. 10.1093/rheumatology/kei023, 16105911.
12. Vossenaar ER, van Venrooij WJ. Citrullinated proteins: sparks that may ignite the fire in rheumatoid arthritis. Arthritis Res Ther 2004, 6:107-111. 10.1186/ar1184, 416453, 15142259.
13. Srebrow A, Blaustein M, Kornblihtt AR. Regulation of fibronectin alternative splicing by a basement membrane-like extracellular matrix. FEBS Lett 2002, 514:285-289. 10.1016/S0014-5793(02)02382-7, 11943167.
14. Walle TK, Vartio T, Helve T, Virtanen HI, Kurki R. Cellular fibronectin in rheumatoid synovium and synovial fluid: a possible factor contributing to lymphocytic infiltration. Scand J Immtmol 1990, 31:535-540.
15. Barilla ML, Carsons SE. Fibronectin fragments and their role in inflammatory arthritis. Semin Arthritis Rheum 2000, 29:252-265. 10.1016/S0049-0172(00)80012-8, 10707992.
16. Shiozawa K, Hino K, Shiozawa S. Alternatively spliced EDA-containing fibronectin in synovial fluid as a predictor of rheumatoid joint destruction. Rheumatology (Oxford) 2001, 40:739-472.
17. Luban S, Li ZG. Citrullinated peptide and its relevance to rheumatoid arthritis: an update. Int J Rheum Dis 2010, 13:284-287. 10.1111/j.1756-185X.2010.01553.x, 21199462.
18. Pruijn GJ, Wiik A, van Venrooij WJ. The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis. Arthritis Res Ther 2010, 12:203. 10.1186/ar2903, 2875630, 20236483.
19. Konttinen YT, Nykänen P, Nordström D, Saari H, Sandelin J, Santavirta S, Kouri T. DNA synthesis in prolyl 4-hydroxylase positive fibroblasts in situ in synovial tissue. An autoradiography-immunoperoxidase double labeling study. J Rheumatol 1989, 16:339-345.
20. Mohr W, Hummler N, Pelster B, Wessinghage D. Proliferation of pannus tissue cells in rheumatoid arthritis. Rheumatol Int 1986, 6:127-132. 10.1007/BF00270349, 3749730.
21. Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M, Tanigawa N. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clinical Cancer Research 2000, 6:127-134.
22. Blanc-Brude OP, Mesri M, Wall NR, Plescia J, Dohi T, Altieri DC. Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis. Clin Cancer Res 2003, 9:2683-2692.
23. Choy EH, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001, 344:907-916. 10.1056/NEJM200103223441207, 11259725.
24. Dayer JM. Interleukin 1 or tumor necrosis factor-alpha: which is the real target in rheumatoid arthritis?. J Rheumatol 2002, 65(Suppl):10-5.
25. Kotake S, Udagawa N, Hakoda M, Mogi M, Yano K, Tsuda E, Takahashi K, Furuya T, Ishiyama S, Kim KJ, Saito S, Nishikawa T, Takahashi N, Togari A, Tomatsu T, Suda T, Kamatani N. Activated human T cells directly induce osteoclastogenesis from human monocytes: Possible role of T cells in bone destruction in rheumatoid arthritis patients. Arthritis Rheum 2001, 44:1003-1012. 10.1002/1529-0131(200105)44:5<1003::AID-ANR179>3.0.CO;2-#, 11352231.
26. Takayanagi H, Iizuka H, Juji T, Nakagawa T, Yamamoto A, Miyazaki T, Koshihara Y, Oda H, Nakamura K, Tanaka S. Involvement of receptor activator of nuclear factor kappa B ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum 2000, 43:259-269. 10.1002/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W, 10693864.
27. Skoumal M, Kolarz G, Haberhauer G, Woloszczuk W, Hawa G, Klingler A. Osteoprotegerin and the receptor activator of NF-kappa B ligand in the serum and synovial fluid. A comparison of patients with longstanding rheumatoid arthritis and osteoarthritis. Rheumatol Int 2005, 26:63-69. 10.1007/s00296-004-0579-1, 15889303.
28. Gravallese EM, Manning C, Tsay A, Naito A, Pan C, Amento E, Goldring SR. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum 2000, 43:250-258. 10.1002/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P, 10693863.
29. Page G, Miossec P. RANK and RANKL expression as markers of dendritic cell-T cell interactions in paired samples of rheumatoid synovium and lymph nodes. Arthritis Rheum 2005, 52:2307-2312. 10.1002/art.21211, 16052586.
30. Chang X, Yamada R, Suzuki A, Sawada T, Yoshino S, Tokuhiro S, Yamamoto K. Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis. Rheumatology 2005, 44:40-50. 10.1093/rheumatology/keh414, 15466895.
31. Chang X, Zhao Y, Sun S, Zhang Y, Zhu Y. The expression of PADI4 in synovium of rheumatoid arthritis. Rheumatol Int 2009, 29:1411-1416. 10.1007/s00296-009-0870-2, 19199100.
32. Fan LY, He DY, Wang Q, Zong M, Zhang H, Yang L, LS Sun LS. Citrullinated vimentin stimulates proliferation, pro-inflammatory cytokine secretion, and PADI4 and RANKL expression of fibroblast-like synoviocytes in rheumatoid arthritis. Scand J Rheumatol 2012, 41:354-358. 10.3109/03009742.2012.670263, 22765310.